Lemaitre Vascular (LMAT) Tops Q4 EPS by 2c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
LeMaitre Q4 2023 Financial Results
February 27, 2024 4:05 PM ESTBURLINGTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq: LMAT), a provider of vascular devices, implants and services, today reported Q4 2023 results, announced a $0.16/share quarterly dividend and provided guidance.
Q4 2023 Financial Results
Sales $48.9mm, +19% (+14% organic) vs. Q4 2022Gross margin 68.1%, +450 bpsOp. income $10.2mm, +46%Op. margin 21%Net income $8.5mm, +50%Earnings per diluted share $0.38, +49%Cash up $8.1mm sequentially to $105.1mmBovine patches (+18%), allografts (+52%), valvulotomes (+12%), carotid shunts (+16%) and distributed porcine patches drove Q4 sales. EMEA sales increased 21%, the Americas 20% and APAC 11%.
The... More
